Setting Policies for Consumer Communications a Behavioral Decision Research Approach

The authors offer a framework rooted in behavioral decision research for the evaluation and regulation of communications. The approach considers consumer interpretations of product communications, the sensitivity of choice to such judgments, and the acceptability of misunderstanding to regulators.

[1]  Colin Camerer,et al.  Regulation for Conservatives: Behavioral Economics and the Case for 'Asymmetric Paternalism' , 2003 .

[2]  B. Fischhoff,et al.  Giving advice. Decision theory perspectives on sexual assault. , 1992, American Psychologist.

[3]  Christine Moorman,et al.  A Quasi Experiment to Assess the Consumer and Informational Determinants of Nutrition Information Processing Activities: The Case of the Nutrition Labeling and Education Act , 1996 .

[4]  Eric J. Johnson,et al.  The adaptive decision maker , 1993 .

[5]  Rocky Ross,et al.  Mental models , 2004, SIGA.

[6]  Baruch Fischhoff,et al.  Setting Standards: A Systematic Approach to Managing Public Health and Safety Risks , 1984 .

[7]  B. Fischhoff,et al.  Scientific management of science? , 2000 .

[8]  J. Kagan,et al.  Rational choice in an uncertain world , 1988 .

[9]  C. Geiger.  Health claims: history, current regulatory status, and consumer research. , 1998, Journal of the American Dietetic Association.

[10]  John E. Calfee,et al.  Public Policy Issues in Health Claims for Foods , 1991 .

[11]  B Fischhoff,et al.  Giving advice. Decision theory perspectives on sexual assault. , 1992, The American psychologist.

[12]  P. Slovic.  Perception of risk. , 1987, Science.

[13]  B Fischhoff,et al.  Why (cancer) risk communication can be hard. , 1999, Journal of the National Cancer Institute. Monographs.

[14]  J. Emord.  Pearson v. Shalala: The Beginning of the End for FDA Speech Suppression , 2000 .

[15]  Mitchell J. Small,et al.  What information belongs in a warning , 1998 .

[16]  D. Scammon,et al.  Health Claims and Disclaimers: Extended Boundaries and Research Opportunities in Consumer Interpretation , 2000 .

[17]  M. J. Quadrel,et al.  Risk perception and communication , 2008 .

[18]  H. Simon,et al.  Models of Man. , 1957 .

[19]  B. Johnson.  Risk Communication: A Mental Models Approach , 2002 .

[20]  M. Barry,et al.  Patient Reactions to a Program Designed to Facilitate Patient Participation in Treatment Decisions for Benign Prostatic Hyperplasia , 1995, Medical care.

[21]  Tammy O. Tengs,et al.  One thousand health-related quality-of-life estimates. , 2000, Medical care.

[22]  A. Tversky,et al.  Judgment under Uncertainty: Heuristics and Biases , 1974, Science.

[23]  Lisa M. Schwartz,et al.  How can we help people make sense of medical data? , 1999, Effective clinical practice : ECP.

[24]  Elizabeth A. Casman,et al.  An Integrated Risk Model of a Drinking‐Water – Borne Cryptosporidiosis Outbreak , 2000, Risk analysis : an official publication of the Society for Risk Analysis.

[25]  Adrian Furnham,et al.  8 – Lay Theories in Law , 1988 .

[26]  John W. Payne,et al.  The adaptive decision maker: Name index , 1993 .

[27]  B Fischhoff,et al.  Evaluating the Effectiveness of Risk‐Reduction Strategies for Consumer Chemical Products , 2001, Risk analysis : an official publication of the Society for Risk Analysis.

[28]  David Vladeck.  Truth and Consequences: The Perils of Half-Truths and Unsubstantiated Health Claims for Dietary Supplements , 2000 .

[29]  Adrian Furnham,et al.  Lay Theories: Everyday Understanding of Problems in the Social Sciences , 1988 .

[30]  W. Edwards,et al.  Decision Analysis and Behavioral Research , 1986 .

[31]  B Fischhoff,et al.  Informed consent does not mean rational consent. Cognitive limitations on decision-making. , 1990, The Journal of legal medicine.

[32]  A. Partin,et al.  Effects of a saw palmetto herbal blend in men with symptomatic benign prostatic hyperplasia. , 2000, The Journal of urology.

[33]  Christine Jolls,et al.  A Behavioral Approach to Law and Economics , 1998 .

[34]  P. Kline.  Models of man , 1986, Nature.

[35]  E. Ernst.  The RiskBenefit Profile of Commonly Used Herbal Therapies: Ginkgo, St. John's Wort, Ginseng, Echinacea, Saw Palmetto, and Kava , 2002, Annals of Internal Medicine.

[36]  I. Ritov,et al.  Emotion-based choice , 1999 .

[37]  T. Wilt,et al.  Saw palmetto extracts for treatment of benign prostatic hyperplasia: a systematic review. , 1998, JAMA.

[38]  M. Barry,et al.  The American Urological Association symptom index for benign prostatic hyperplasia. The Measurement Committee of the American Urological Association. , 1992, The Journal of urology.

[39]  D. Kahneman,et al.  Heuristics and Biases: The Psychology of Intuitive Judgment , 2002 .

[40]  Douglas A. Kysar,et al.  Taking Behavioralism Seriously: The Problem of Market Manipulation , 1999 .

[41]  R. Dawes.  Judgment under uncertainty: The robust beauty of improper linear models in decision making , 1979 .

[42]  Michael S. Wogalter,et al.  Do Product Warnings Increase Safe Behavior? A Meta-Analysis , 1997 .

[43]  Regulations on statements made for dietary supplements concerning the effect of the product on the structure or function of the body. Food and Drug Administration, HHS. Final rule. , 2000, Federal register.

[44]  H. Woo,et al.  A comparison of techniques for eliciting patient preferences in patients with benign prostatic hyperplasia. , 2002, The Journal of urology.

[45]  Guidance for Industry Significant Scientific Agreement in the Review of Health Claims for Conventional Foods and Dietary Supplements , 1999 .